Skip to main content

Advertisement

Log in

Therapeutic effects of heme oxygenase-1 on psoriasiform skin lesions in guinea pigs

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Heme oxygenase-1 (HO-1) has been shown to exert immunosuppressive, anti-inflammatory, anti-apoptotic and anti-proliferative effects. Its unique positive effects indicate that this enzyme might be a potential therapeutic target for psoriasis. To determine the effect of pharmacologic up-regulation of HO-1 on psoriasis, we generated a guinea pig model of psoriasiform skin lesions using propranolol induction. In this in vivo model, the 3-week propranolol challenge generated the psoriasiform pathological changes on the ears of guinea pigs. And then, guinea pigs were intraperitoneally injected with 5 mg/kg cobalt protoporphyrin (CoPP), a potent HO-1 inducer, 20 mg/kg zinc protoporphyrin, an inhibitor of HO-1, or PBS as controls, once a week from 9 weeks of age to 14 weeks old. CoPP induced notably HO-1 expression at both mRNA and protein levels. Moreover, CoPP treatment led to a significant reduction of the psoriasiform histopathological changes and remarkable amelioration of the psoriasiform skin lesions, compared with PBS treatment, with a concomitant reduction in proliferating cell nuclear antigen expression. Additionally, CoPP treatment resulted in a decreased TNF-α and significantly increased IL-10 release. Our results suggest that HO-1 induction therapy ameliorates the psoriasiform skin lesions by suppressing keratinocyte hyperproliferation and attenuating production of inflammatory responses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Akamatsu Y, Haga M, Tyagi S, Yamashita K, Graca-Souza AV, Ollinger R, Czismadia E, May GA, Ifedigbo E, Otterbein LE, Bach FH, Soares MP (2004) Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury. FASEB J 18:771–772

    PubMed  CAS  Google Scholar 

  2. Allanson M, Reeve VE (2005) Ultraviolet A (320–400 nm) modulation of ultraviolet B (290–320 nm)-induced immune suppression is mediated by carbon monoxide. J Invest Dermatol 124:644–650. doi:10.1111/j.0022-202X.2005.23614.x

    Article  PubMed  CAS  Google Scholar 

  3. Asadullah K, Sabat R, Wiese A, Docke WD, Volk HD, Sterry W (1999) Interleukin-10 in cutaneous disorders: implications for its pathophysiological importance and therapeutic use. Arch Dermatol Res 291:628–636. doi:10.1007/s004030050467

    Article  PubMed  CAS  Google Scholar 

  4. Baker BS, Brent L, Valdimarsson H, Powles AV, al-Imara L, Walker M, Fry L (1992) Is epidermal cell proliferation in psoriatic skin grafts on nude mice driven by T-cell derived cytokines? Br J Dermatol 126:105–110. doi:10.1111/j.1365-2133.1992.tb07805.x

    Article  PubMed  CAS  Google Scholar 

  5. Bos JD, de Rie MA, Teunissen MB, Piskin G (2005) Psoriasis: dysregulation of innate immunity. Br J Dermatol 152:1098–1107. doi:10.1111/j.1365-2133.2005.06645.x

    Article  PubMed  CAS  Google Scholar 

  6. Clark JE, Green CJ, Motterlini R (1997) Involvement of the heme oxygenase–carbon monoxide pathway in keratinocyte proliferation. Biochem Biophys Res Commun 241:215–220. doi:10.1006/bbrc.1997.7742

    Article  PubMed  CAS  Google Scholar 

  7. Dika E, Varotti C, Bardazzi F, Maibach HI (2006) Drug-induced psoriasis: an evidence-based overview and the introduction of psoriatic drug eruption probability score. Cutan Ocul Toxicol 25:1–11. doi:10.1080/15569520500536568

    Article  PubMed  CAS  Google Scholar 

  8. Drechsler Y, Dolganiuc A, Norkina O, Romics L, Li W, Kodys K, Bach FH, Mandrekar P, Szabo G (2006) Heme oxygenase-1 mediates the anti-inflammatory effects of acute alcohol on IL-10 induction involving p38 MAPK activation in monocytes. J Immunol 177:2592–2600

    PubMed  CAS  Google Scholar 

  9. Yaping E, Golden SC, Shalita AR, Lee WL, Maes DH, Matsui MS (2006) Neuropeptide (calcitonin gene-related peptide) induction of nitric oxide in human keratinocytes in vitro. J Invest Dermatol 126:1994–2001. doi:10.1038/sj.jid.5700349

    Google Scholar 

  10. Gaylarde PM, Brock AP, Sarkany I (1978) Psoriasiform changes in guinea-pig skin from propranolol. Clin Exp Dermatol 3:157–160. doi:10.1111/j.1365-2230.1978.tb01479.x

    Article  PubMed  CAS  Google Scholar 

  11. Hanselmann C, Mauch C, Werner S (2001) Haem oxygenase-1: a novel player in cutaneous wound repair and psoriasis? Biochem J 353:459–466. doi:10.1042/0264-6021:3530459

    Article  PubMed  CAS  Google Scholar 

  12. Hirai K, Sasahira T, Ohmori H, Fujii K, Kuniyasu H (2007) Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice. Int J Cancer 120:500–505. doi:10.1002/ijc.22287

    Article  PubMed  CAS  Google Scholar 

  13. Inoue S, Suzuki M, Nagashima Y, Suzuki S, Hashiba T, Tsuburai T, Ikehara K, Matsuse T, Ishigatsubo Y (2001) Transfer of heme oxygenase 1 cDNA by a replication-deficient adenovirus enhances interleukin 10 production from alveolar macrophages that attenuates lipopolysaccharide-induced acute lung injury in mice. Hum Gene Ther 12:967–979. doi:10.1089/104303401750195926

    Article  PubMed  CAS  Google Scholar 

  14. Kie JH, Kapturczak MH, Traylor A, Agarwal A, Hill-Kapturczak N (2008) Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis. J Am Soc Nephrol 19:1681–1691. doi:10.1681/ASN.2007101099

    Article  PubMed  CAS  Google Scholar 

  15. Kirino M, Kirino Y, Takeno M, Nagashima Y, Takahashi K, Kobayashi M, Murakami S, Hirasawa T, Ueda A, Aihara M, Ikezawa Z, Ishigatsubo Y (2008) Heme oxygenase 1 attenuates the development of atopic dermatitis-like lesions in mice: implications for human disease. J Allergy Clin Immunol 122:290–297. doi:10.1016/j.jaci.2008.05.031

    Article  PubMed  CAS  Google Scholar 

  16. Lee BS, Shim SM, Heo J, Pae HO, Seo BY, Han SY, Sohn DH, Jang SI, Chung HT (2007) Wogonin suppresses TARC expression induced by mite antigen via heme oxygenase 1 in human keratinocytes. Suppressive effect of wogonin on mite antigen-induced TARC expression. J Dermatol Sci 46:31–40. doi:10.1016/j.jdermsci.2007.01.001

    Article  PubMed  CAS  Google Scholar 

  17. Listopad J, Asadullah K, Sievers C, Ritter T, Meisel C, Sabat R, Docke WD (2007) Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells. Exp Dermatol 16:661–670. doi:10.1111/j.1600-0625.2007.00581.x

    Article  PubMed  CAS  Google Scholar 

  18. McDaid J, Yamashita K, Chora A, Ollinger R, Strom TB, Li XC, Bach FH, Soares MP (2005) Heme oxygenase-1 modulates the allo-immune response by promoting activation-induced cell death of T cells. FASEB J 19:458–460

    PubMed  CAS  Google Scholar 

  19. Morse D, Choi AM (2002) Heme oxygenase-1: the “emerging molecule” has arrived. Am J Respir Cell Mol Biol 27:8–16

    PubMed  CAS  Google Scholar 

  20. Numerof RP, Asadullah K (2006) Cytokine and anti-cytokine therapies for psoriasis and atopic dermatitis. BioDrugs 20:93–103. doi:10.2165/00063030-200620020-00004

    Article  PubMed  CAS  Google Scholar 

  21. Otterbein LE, Soares MP, Yamashita K, Bach FH (2003) Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 24:449–455. doi:10.1016/S1471-4906(03)00181-9

    Article  PubMed  CAS  Google Scholar 

  22. Pae HO, Ae Ha Y, Chai KY, Chung HT (2008) Heme oxygenase-1 attenuates contact hypersensitivity induced by 2, 4-dinitrofluorobenzene in mice. Immunopharmacol Immunotoxicol 30:207–216. doi:10.1080/08923970801946824

    Article  PubMed  CAS  Google Scholar 

  23. Pae HO, Oh GS, Choi BM, Chae SC, Chung HT (2003) Differential expressions of heme oxygenase-1 gene in CD25- and CD25 + subsets of human CD4 + T cells. Biochem Biophys Res Commun 306:701–705. doi:10.1016/S0006-291X(03)01037-4

    Article  PubMed  CAS  Google Scholar 

  24. Pae HO, Oh GS, Choi BM, Chae SC, Kim YM, Chung KR, Chung HT (2004) Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 172:4744–4751

    PubMed  CAS  Google Scholar 

  25. Paul G, Bataille F, Obermeier F, Bock J, Klebl F, Strauch U, Lochbaum D, Rummele P, Farkas S, Scholmerich J, Fleck M, Rogler G, Herfarth H (2005) Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis. Clin Exp Immunol 140:547–555. doi:10.1111/j.1365-2249.2005.02775.x

    Article  PubMed  CAS  Google Scholar 

  26. Sato T, Takeno M, Honma K, Yamauchi H, Saito Y, Sasaki T, Morikubo H, Nagashima Y, Takagi S, Yamanaka K, Kaneko T, Ishigatsubo Y (2006) Heme oxygenase-1, a potential biomarker of chronic silicosis, attenuates silica-induced lung injury. Am J Respir Crit Care Med 174:906–914. doi:10.1164/rccm.200508-1237OC

    Article  PubMed  CAS  Google Scholar 

  27. Song R, Kubo M, Morse D, Zhou Z, Zhang X, Dauber JH, Fabisiak J, Alber SM, Watkins SC, Zuckerbraun BS, Otterbein LE, Ning W, Oury TD, Lee PJ, McCurry KR, Choi AM (2003) Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am J Pathol 163:231–242

    PubMed  CAS  Google Scholar 

  28. Song R, Mahidhara RS, Zhou Z, Hoffman RA, Seol DW, Flavell RA, Billiar TR, Otterbein LE, Choi AM (2004) Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J Immunol 172:1220–1226

    PubMed  CAS  Google Scholar 

  29. Takeda Y, Takeno M, Iwasaki M, Kobayashi H, Kirino Y, Ueda A, Nagahama K, Aoki I, Ishigatsubo Y (2004) Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody. Clin Exp Immunol 138:237–244. doi:10.1111/j.1365-2249.2004.02594.x

    Article  PubMed  CAS  Google Scholar 

  30. Trigona WL, Porter CM, Horvath-Arcidiacono JA, Majumdar AS, Bloom ET (2007) Could heme-oxygenase-1 have a role in modulating the recipient immune response to embryonic stem cells? Antioxid Redox Signal 9:751–756. doi:10.1089/ars.2007.1602

    Article  PubMed  CAS  Google Scholar 

  31. True AL, Olive M, Boehm M, San H, Westrick RJ, Raghavachari N, Xu X, Lynn EG, Sack MN, Munson PJ, Gladwin MT, Nabel EG (2007) Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ Res 101:893–901. doi:10.1161/CIRCRESAHA.107.158998

    Article  PubMed  CAS  Google Scholar 

  32. Tsankov N, Angelova I, Kazandjieva J (2000) Drug-induced psoriasis. Recognition and management. Am J Clin Dermatol 1:159–165. doi:10.2165/00128071-200001030-00003

    Article  PubMed  CAS  Google Scholar 

  33. Tullius SG, Nieminen-Kelha M, Buelow R, Reutzel-Selke A, Martins PN, Pratschke J, Bachmann U, Lehmann M, Southard D, Iyer S, Schmidbauer G, Sawitzki B, Reinke P, Neuhaus P, Volk HD (2002) Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation 74:591–598. doi:10.1097/00007890-200209150-00001

    Article  PubMed  CAS  Google Scholar 

  34. Willoughby DA, Moore AR, Colville-Nash PR, Gilroy D (2000) Resolution of inflammation. Int J Immunopharmacol 22:1131–1135. doi:10.1016/S0192-0561(00)00064-3

    Article  PubMed  CAS  Google Scholar 

  35. Wojas-Pelc A, Marcinkiewicz J (2007) What is a role of haeme oxygenase-1 in psoriasis? Current concepts of pathogenesis. Int J Exp Pathol 88:95–102. doi:10.1111/j.1365-2613.2006.00505.x

    Article  PubMed  CAS  Google Scholar 

  36. Woo J, Iyer S, Cornejo MC, Mori N, Gao L, Sipos I, Maines M, Buelow R (1998) Stress protein-induced immunosuppression: inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32). Transpl Immunol 6:84–93. doi:10.1016/S0966-3274(98)80022-1

    Article  PubMed  CAS  Google Scholar 

  37. Xia ZW, Zhong WW, Xu LQ, Sun JL, Shen QX, Wang JG, Shao J, Li YZ, Yu SC (2006) Heme oxygenase-1-mediated CD4 + CD25high regulatory T cells suppress allergic airway inflammation. J Immunol 177:5936–5945

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Hua-Cheng Zhou for his technical assistances, and Chang-Yi Cui for his critical review of the manuscript.

Conflict of interest statement

This paper has no conflicts of interest. We have not a financial relationship with the organization that sponsored the research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yu-Zhen Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ma, L.J., You, Y., Bai, B.X. et al. Therapeutic effects of heme oxygenase-1 on psoriasiform skin lesions in guinea pigs. Arch Dermatol Res 301, 459–466 (2009). https://doi.org/10.1007/s00403-009-0956-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-009-0956-4

Keywords

Navigation